Results 171 to 174 of about 1,997 (174)

FIRST TIME USE OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, UAE

Atherosclerosis
Sarah Qureshi
semanticscholar   +1 more source

Lomitapide in Pediatric Patients with Homozygous Familial Hypercholesterolemia – Analysis of Secondary and Safety Endpoints from the APH-19 Study

Journal of Clinical Lipidology
C. Schmitt, Alberto Zambon, C. Taylan, J. Driemeyer, Hofit Cohen, P. Buonuomo, A. Alashwal, M. Al-Dubayee, J. Díaz-Díaz, Faouzi Maatouk, Sergio Martínez-Hervás, Brian Mangal, Naji Kholaif, S. Löwe, Zsuzsanna Tamas, Luis Masana   +15 more
semanticscholar   +1 more source

Lomitapide in paediatric patients with homozygous familial hypercholesterolaemia (HoFH) – analysis of patient-level LDL-C reduction, fat soluble vitamins, lipoproteins and patient maturation from APH-19 study

Atherosclerosis
Lluís Masana, Alberto Zambon, C. Schmitt, C. Taylan, Joenna Dreimeyer, Hofit Cohen, P. Buonuomo, A. Alashwal, M. Al-Dubayee, J. Díaz-Díaz, Faouzi Maatouk, Sergio Martínez-Hervás, Brian Mangal, Naji Kholaif, S. Löwe, Zsuzsanna Tamas   +15 more
semanticscholar   +1 more source

LOMITAPIDE PHASE-3 STUDY IN PEDIATRIC HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): APH-19

Atherosclerosis
Naji Kholaif, Luis Masana, Alberto Zambon, C. Schmitt, C. Taylan, J. Driemeyer, Hofit Cohen, P. Buonuomo, A. Alashwal, Mohammad Al-Dubayee, J. Díaz-Díaz, Faouzi Maatouk, Sergio Martínez-Hervás, Brian Mangal, Sandra Lowe, Zsuzsanna Tamas   +15 more
semanticscholar   +1 more source